Pluri Inc. (PLUR) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Available-for-sale Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 32.72M USD | Liabilities, Current |
| Cash and equivalents | 3.53M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current · Available-for-sale Securities, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $32.72M | $3.53M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $32.01M | $3.42M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $32.35M | $4.69M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $32.16M | $4.26M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $32.33M | $5.89M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $5.71M | $8.50M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $4.44M | $7.23M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $4.58M | $3.20M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $4.45M | $6.78M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $4.53M | $7.08M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $4.53M | $5.47M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $4.32M | $5.25M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $5.62M | $5.36M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $5.38M | $3.68M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $5.28M | $8.82M | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $5.02M | $8.74M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $6.83M | $9.77M | (m) | $3.00K | (m) | (m) |
| 2022-03-31 | (m) | $7.82M | $23.79M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $9.60M | $18.71M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $10.37M | $14.61M | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $11.52M | $31.24M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $9.92M | $12.27M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $10.00M | $7.82M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $8.35M | $6.63M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $7.99M | $8.27M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $7.20M | $6.76M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $6.99M | $7.30M | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $7.84M | $3.71M | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $8.16M | $4.11M | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $8.25M | $9.54M | (m) | $285.00K | (m) | (m) |
| 2018-12-31 | (m) | $7.23M | $6.80M | (m) | $82.00K | (m) | (m) |
| 2018-09-30 | (m) | $7.40M | $8.43M | (m) | $37.00K | (m) | (m) |
| 2018-06-30 | (m) | $8.55M | $8.82M | (m) | $58.00K | (m) | (m) |
| 2018-03-31 | (m) | $7.81M | $5.94M | (m) | $596.00K | (m) | (m) |
| 2017-12-31 | $19.49M | $5.80M | $8.58M | $10.74M | $172.00K | (m) | 3.36× |
| 2017-09-30 | $18.62M | $4.77M | $12.29M | $6.30M | $25.00K | (m) | 3.90× |
| 2017-06-30 | $20.91M | $5.41M | $4.71M | $15.16M | $1.04M | (m) | 3.86× |
| 2017-03-31 | $20.48M | $6.13M | $5.32M | $14.84M | $318.00K | (m) | 3.34× |
| 2016-12-31 | $21.66M | $5.38M | $7.33M | $14.04M | $287.00K | (m) | 4.03× |
| 2016-09-30 | $22.49M | $5.37M | $6.10M | $15.93M | $459.00K | (m) | 4.18× |
| 2016-06-30 | $25.87M | $5.78M | $6.22M | $17.41M | $2.23M | (m) | 4.48× |
| 2016-03-31 | $26.35M | $4.81M | $5.40M | $20.77M | $180.00K | (m) | 5.48× |
| 2015-12-31 | $26.73M | $4.61M | $4.95M | $21.64M | $150.00K | (m) | 5.80× |
| 2015-09-30 | $31.53M | $4.24M | $10.80M | $20.31M | $419.00K | (m) | 7.43× |
| 2015-06-30 | $46.57M | $6.18M | $22.63M | $22.25M | $1.69M | (m) | 7.53× |
| 2015-03-31 | $30.39M | $5.02M | $8.94M | $21.25M | $204.00K | (m) | 6.06× |
| 2014-12-31 | $32.82M | $5.17M | $6.96M | $25.70M | $158.00K | (m) | 6.34× |
| 2014-09-30 | $32.01M | $5.99M | $5.66M | $25.90M | $451.00K | (m) | 5.35× |
| 2014-06-30 | $36.72M | $7.40M | $4.49M | $29.96M | $2.26M | (m) | 4.96× |
| 2014-03-31 | (m) | $6.44M | $3.64M | $30.35M | (m) | (m) | (m) |
| 2013-12-31 | (m) | $5.58M | $4.63M | $28.78M | (m) | (m) | (m) |
| 2013-09-30 | (m) | $5.73M | $8.60M | $16.02M | (m) | (m) | (m) |
| 2013-06-30 | (m) | $5.92M | $9.01M | $13.44M | (m) | (m) | (m) |
| 2013-03-31 | (m) | $5.76M | $27.82M | $9.04M | (m) | (m) | (m) |
| 2012-12-31 | (m) | $6.13K | $23.55K | $8.88K | (m) | (m) | (m) |
| 2012-09-30 | (m) | $5.23M | $38.75M | $8.13M | (m) | (m) | (m) |
| 2012-06-30 | (m) | $5.52M | $9.39M | $7.02M | (m) | (m) | (m) |
| 2012-03-31 | (m) | $4.85M | $11.61M | $6.04M | (m) | (m) | (m) |
| 2011-12-31 | (m) | $4.98M | $6.67M | $4.35M | (m) | (m) | (m) |
| 2011-09-30 | (m) | $5.04M | $13.63M | $513.00K | (m) | (m) | (m) |
| 2011-06-30 | (m) | $2.02M | $42.83M | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | $44.87M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $4.74M | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | $1.13M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $1.58M | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | $2.34M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |